BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Autoimmunity
,
Lipopolysaccharide
,
rs2230926
,
VEGFA
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
GPBAR1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Sigmoid colon
Ascending colon
Rectum colon
Transverse colon
Cecum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Septicemia due to Klebsiella
Malaria
Sepsis due to Escherichia coli
Disease due to Gammaherpesvirinae
Sepsis due to Serratia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
fluarix
NQ Y15
11-ketotestosterone
SP600125
Yellow Fever Vaccine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
LINC02575
DUX4
ZRSR2
PRKCZ
BHLHE41
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy.
TGR5 deficiency-induced anxiety and depression-like behaviors: The role of gut microbiota dysbiosis.
Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy.
Gut microbiota-mediated ursodeoxycholic acids regulate the inflammation of microglia through TGR5 si…
The bile acid receptor TGR5 inhibits platelet activation and thrombus formation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type …
Gut Microbiota and Modulation of Liver Damage in NAFLD
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ